Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional Therapy.
Gregory K, Hansen D, Penglase R, Apostolopoulos D, Ngian GS, Stevens W, Morrisroe K, Ferdowsi N, Ross L, Walker J, Cooley H, Youssef P, Tymms K, Host L, Proudman S, Moore J, Nikpour M, Sahhar J. Gregory K, et al. Among authors: tymms k. Arthritis Rheumatol. 2024 Apr 1. doi: 10.1002/art.42850. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38560777
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group.
Kordkheili AM, Bekker C, Hoens AM, Voshaar M, Campbell W, Carmona L, de Wit M, March L, Nielsen SM, Shea BJ, Toupin-April K, Tugwell P, Tymms K, Kelly A; Adherence Working Group. Kordkheili AM, et al. Among authors: tymms k. Semin Arthritis Rheum. 2024 Jun;66:152411. doi: 10.1016/j.semarthrit.2024.152411. Epub 2024 Feb 13. Semin Arthritis Rheum. 2024. PMID: 38537323
Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
Kelly A, Tong A, Tymms K, March L, Craig JC, De Vera M, Evans V, Hassett G, Toupin-April K, van den Bemt B, Teixeira-Pinto A, Alten R, Bartlett SJ, Campbell W, Dawson T, Gill M, Hebing R, Meara A, Nieuwlaat R, Shaw Y, Singh JA, Suarez-Almazor M, Sumpton D, Wong P, Christensen R, Beaton D, de Wit M, Tugwell P; OMERACT-Adherence Group. Kelly A, et al. Among authors: tymms k. Trials. 2018 Mar 27;19(1):204. doi: 10.1186/s13063-018-2565-z. Trials. 2018. PMID: 29587864 Free PMC article.
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia.
Deakin CT, De Stavola BL, Littlejohn G, Griffiths H, Ciciriello S, Youssef P, Mathers D, Bird P, Smith T, O'Sullivan C, Freeman T, Segelov D, Hoffman D, Seaman SR; OPAL Rheumatology Network. Deakin CT, et al. JAMA Netw Open. 2023 Jun 1;6(6):e2320851. doi: 10.1001/jamanetworkopen.2023.20851. JAMA Netw Open. 2023. PMID: 37382956 Free PMC article. Clinical Trial.
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
Fairley JL, Hansen D, Ross L, Proudman S, Sahhar J, Ngian GS, Walker J, Host LV, Morrisroe K, Apostolopoulous D, Ferdowsi N, Wilson M, Tabesh M, Stevens W, Nikpour M; Australian Scleroderma Interest Group. Fairley JL, et al. Arthritis Res Ther. 2023 May 12;25(1):77. doi: 10.1186/s13075-023-03059-x. Arthritis Res Ther. 2023. PMID: 37173780 Free PMC article.
A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis-Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study.
Jee AS, Stewart I, Youssef P, Adelstein S, Lai D, Hua S, Stevens W, Proudman S, Ngian GS, Glaspole IN, Moodley YP, Bleasel JF, Macansh S, Nikpour M, Sahhar J, Corte TJ; Australian Scleroderma Cohort Study, Australian Scleroderma Interest Group, Australian Idiopathic Pulmonary Fibrosis Registry, and associated investigators. Jee AS, et al. Arthritis Rheumatol. 2023 Aug;75(8):1424-1433. doi: 10.1002/art.42491. Epub 2023 May 15. Arthritis Rheumatol. 2023. PMID: 36908055
A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience.
Tymms K, O'Sullivan C, Smith T, Littlejohn G, Freeman T, Hoffman D, Segelov D, Griffiths H, Ciciriello S, Youssef P, Mathers D, Deakin CT. Tymms K, et al. Front Digit Health. 2023 Jan 9;4:1074931. doi: 10.3389/fdgth.2022.1074931. eCollection 2022. Front Digit Health. 2023. PMID: 36698650 Free PMC article.
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis.
Kerick M, Acosta-Herrera M, Simeón-Aznar CP, Callejas JL, Assassi S; International SSc Group; Proudman SM, Nikpour M; Australian Scleroderma Interest Group (ASIG); PRECISESADS Clinical Consortium; Hunzelmann N, Moroncini G, de Vries-Bouwstra JK, Orozco G, Barton A, Herrick AL, Terao C, Allanore Y, Fonseca C, Alarcón-Riquelme ME, Radstake TRDJ, Beretta L, Denton CP, Mayes MD, Martin J. Kerick M, et al. NPJ Genom Med. 2022 Oct 5;7(1):57. doi: 10.1038/s41525-022-00327-8. NPJ Genom Med. 2022. PMID: 36198672 Free PMC article.
Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning-do we need 200 mg/kg cyclophosphamide?
Penglase R, Englert H, Tymms K, Carr A, Ma D, Milliken S, Moore J. Penglase R, et al. Among authors: tymms k. Bone Marrow Transplant. 2022 Jul;57(7):1207-1209. doi: 10.1038/s41409-022-01696-5. Epub 2022 May 6. Bone Marrow Transplant. 2022. PMID: 35523849 No abstract available.
66 results